ERBB2 and breast cancer: In this retrospective cohort study focusing on Moroccan patients with early-stage breast cancer, we did not observe any significant differences in tumor size, histologic grade, lymph node involvement, or OS between HER2-low and HER2-zero tumors in the general population.